David Orain
Novartis (Switzerland) · 50 works · 1,413 citations · h-index 18
Top works
- Linkers and Cleavage Strategies in Solid-Phase Organic Synthesis and Combinatorial Chemistry
- Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection
- Concise Synthesis of 1H‐Pyrazin‐2‐ones and 2‐Aminopyrazines.
- Protecting Groups in Solid-Phase Organic Synthesis
- Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity
- Linkers and Cleavage Strategies in Solid-Phase Organic Synthesis and Combinatorial Chemistry. (Chem. Rev. 2000, 100, 2091. Published on the Web May 6, 2000).
- Structural States of RORγt: X‐ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds
- Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity
- Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations
- A Novel Intramolecular Palladium-Mediated Cyclization for the Synthesis of Substituted 2-(Aryl- or Benzylamino)-4H-1,3-Benzothiazines
- From Solution-Phase Studies to Solid-Phase Synthesis: A New Indole Based Scaffold for Combinatorial Chemistry
- Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo
- Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect
- AMPA Receptor Antagonists: Potential Therapeutic Applications
- Thiazole‐Based IL‐17 Inhibitors Discovered by Scaffold Morphing
- Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists
- BZM055, an Iodinated Radiotracer Candidate for PET and SPECT Imaging of Myelin and FTY720 Brain Distribution
- Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and Angiogenesis
- Efficient Solution and Solid-Phase Synthesis of a 3,9-Diazabicyclo[3.3.1]non-6-en-2-one Scaffold
- Synthesis of Functionalized Deuterioallylic Compounds